English
SpanishTrusted Resources: Education
Scientific literature and patient education texts
Early Diagnosis of Spinal Muscular Atrophy
source: Ugeskrift for laeger
year: 2021
authors: Born AP,Werlauff U
summary/abstract:Untreated spinal muscular atrophy (SMA) causes progressive motor impairment in affected children. Clinical trials of newly developed disease-modifying drugs have shown the greatest effect in young and in pre-symptomatic children as summarised in this review. An application for neonatal screening in Denmark is currently under consideration. Diagnosis and treatment of children with SMA is often delayed, and until a national screening becomes available, the only way to reduce diagnostic delay is to increase the awareness of medical staff and to make information on early signs of SMA available for concerned families.
organization: University of Copenhagen, Denmark; Aarhus University, Denmarkread more
BookmarkRelated Content
-
Biogen Announces New Updates Across Its SMA Research Program at 2022 MDA ConferenceBiogen Inc. announced new data and updat...
-
Implications of Circulating Neurofilaments for Spinal Muscular Atrophy Treatment Early In Life: A Case SeriesThis longitudinal cohort study aimed to ...
-
Nationwide Children’s Spinal Muscular Atrophy ClinicThe SMA Clinic is a joint program betwee...
-
Karen S. Chen, PhDKaren Chen is the Chief Executive Office...
-
Biogen Exercises Option With Ionis to Develop and Commercialize Investigational ASO for SMABiogen, Inc. and Ionis Pharmaceuticals, ...
-
Revised Upper Limb Module in Type II And III Spinal Muscular Atrophy: 24-Month ChangesThe aim of the study was to establish 24...
-
Biogen to Launch Study of Higher Spinraza Dose in Patients With Later Onset SMABiogen announced it intends to initiate ...
Powered by
In partnership with
